Results 261 to 270 of about 16,809,928 (387)
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Scalable, open-access and multidisciplinary data integration pipeline for climate-sensitive diseases. [PDF]
Dasgupta A +12 more
europepmc +1 more source
Durham RCUK Open Access Data Year 4 (Apr2016-Mar2017)
James Bisset +2 more
openalex +1 more source
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
The transition to fully open access: a new era for the Journal of Clinical Monitoring and Computing. [PDF]
Flick M, Lobo FA.
europepmc +1 more source
ScorpDb: A Novel Open-Access Database for Integrative Scorpion Toxinology
Baradaran, Masoumeh +8 more
openalex +1 more source
The TARDis Route Map to Open Access: developing an Institutional Repository Model [PDF]
Jessie M.N. Hey +2 more
openalex

